TGA Approval

CIPTUNEC adalimumab 40 mg/0.4 mL solution for subcutaneous injection pre-filled pen (374373)

ARTG ID

374373

ARTG Name

CIPTUNEC adalimumab 40 mg/0.4 mL solution for subcutaneous injection pre-filled pen

Sponsor

Cipla Australia Pty Ltd

ARTG Date

September 6, 2022

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

CIPLA AUSTRALIA PTY LTD

Ingredient Name

Adalimumab

Empowering clinical research with data-driven insights and AI-powered tools.